Duration of intravenous antibiotic treatment for acute exacerbations of cystic fibrosis: A systematic review: Duration of treatment for acute exacerbations of cystic fibrosis

RECOMMENDED

Pulmonary Fibrosis

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis

Cochrane Database Syst Rev.

Smith S, Rowbotham NJ, Charbek E

doi: 10.1002/14651858.

RECOMMENDED

Pulmonary Fibrosis

Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review

Thorax.

Rowbotham NJ, Smith S, Prayle AP, Robinson KA, Smyth AR

doi: 10.1136/thoraxjnl-

Pulmonary Fibrosis

Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis

Chest.

Hong LT, Liou TG, Deka R, King JB, Stevens V, Young DC

doi: 10.1016/j.chest.2018.06.002.

Pulmonary Fibrosis

Safety of intravenous tobramycin in combination with a variety of anti-pseudomonal antibiotics in children with cystic fibrosis

SAGE Open Med.

Deschamp AR, Pettit RS, Donaldson JA, Slaven JE, Davis SD

doi: 10.1177/2050312117736694.

RECOMMENDED

Further Publications

A Randomized Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment

★ 2 Recommended by Dr Martin Frey, Faculty Member

★ 3 Recommended by Dr Marcus Hesse, Faculty Member

Am J Respir Crit Care Med

Goss CH, Heltshe SL, West NE, Skalland M, Sanders DB, Jain R, Barto TL, Fogarty B, Marshall BC, VanDevanter DR, Flume PA, STOP2 Investigators.

doi: 10.1164/rccm.202102-0461OC

RECOMMENDED

Further Publications

Treatment of pulmonary exacerbations in cystic fibrosis

★ 3 Recommended by Dr Martin Frey, Faculty Member

Curr Opin Pulm Med.

Ng C, Nadig T, Smyth AR, Flume P

doi: 10.1097/MCP.0000000000000730.

RECOMMENDED

Bronchi

The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis

Lancet Respir Med.

Laska IF, Crichton ML, Shoemark A, Chalmers JD

doi: 10.1016/S2213-2600

RECOMMENDED

Pulmonary Fibrosis

Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: A systematic review

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

J Cyst Fibros

McLeod C, Wood J, Schultz A, Norman R, Smith S, Blyth CC, Webb S, Smyth AR, Snelling TL

doi: 10.1016/j.jcf.2020.08.015

RECOMMENDED

Pulmonary Fibrosis

The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF)

★ 1 Recommended by Dr Martin Frey, Faculty Member

★ 2 Recommended by Dr Marcus Hesse, Faculty Member

J Cyst Fibros

Frost F, Young GR, Wright L, Miah N, Smith DL, Winstanley C, Walshaw MJ, Fothergill JL, Nazareth D

doi: 10.1016/j.jcf.2020.12.012

Related content

Inhaled antibiotics for pulmonary exacerbations in cystic fibrosis

Gaps in the evidence for treatment decisions in cystic fibrosis: a systematic review

Pharmacokinetics of Continuous Infusion Beta-lactams in the Treatment of Acute Pulmonary Exacerbations in Adult Patients With Cystic Fibrosis

Safety of intravenous tobramycin in combination with a variety of anti-pseudomonal antibiotics in children with cystic fibrosis

A Randomized Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment

Treatment of pulmonary exacerbations in cystic fibrosis

The efficacy and safety of inhaled antibiotics for the treatment of bronchiectasis in adults: a systematic review and meta-analysis

Outcomes and endpoints reported in studies of pulmonary exacerbations in people with cystic fibrosis: A systematic review

The clinical and microbiological utility of inhaled aztreonam lysine for the treatment of acute pulmonary exacerbations of cystic fibrosis: An open-label randomised crossover study (AZTEC-CF)